Biotie terminates an exclusive option to acquire Neurelis in a stock deal

Neurelis Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Biotie Therapies Corp.

Finland / Small-Cap Biopharma (<$1 billion)

$211.9m on 06/07/2013 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled